<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Axonics Modulation Technologies, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Axonics Modulation Technologies, Inc.

    Axonics Modulation Technologies, Inc. (NASDAQ:AXNX) is a medical technology company focused on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (“SNM”) solutions. SNM therapy is primarily used to treat patients with overactive bladder (“OAB”), fecal incontinence (“FI”) and urinary retention (“UR”). Axonics currently has marketing approvals in Europe, Canada, and Australia for OAB, FI, and UR. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $400,000,000
    • SIC CODE
      3841
    • NIN CODE
      ####
    • LEADERSHIP
      Raymond W. Cohen
    • FOUNDED
      2012
    • EMPLOYEES
      51-100
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Synthorx, Inc.

    Synthorx, Inc.

    Synthorx is a biotechnology company focused on prolonging and improving the lives ...

    Synthorx is a biotechnology company focused on ...

    Filing Type:    PU
    Anchiano Therapeutics Ltd.

    Anchiano Therapeutics Ltd.

    We are Anchiano Therapeutics, a pivotal-stage biopharmaceutical company focused on...

    We are Anchiano Therapeutics, a pivotal-stage b...

    Filing Type:    PU
    Hylete, Inc

    Hylete, Inc

    HYLETE is a fitness lifestyle brand, founded on the core belief that a company's i...

    HYLETE is a fitness lifestyle brand, founded on...

    Amount Raised:    $1,069,865.00
    Fundraising Status:    EC
    Filing Type:    PURACF
    Clovis Oncology, Inc.

    Clovis Oncology, Inc.

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnolog...

    Founded in 2009, Clovis Oncology (NASDAQ: CLVS)...

    Filing Type:    PU
    Quanterix Corporation

    Quanterix Corporation

    Quanterix is a company that is digitizing biomarker analysis with the goal of adva...

    Quanterix is a company that is digitizing bioma...

    Filing Type:    PU
    Grifols, S.A.

    Grifols, S.A.

    Grifols is a global healthcare company founded in Barcelona in 1909 committed to i...

    Grifols is a global healthcare company founded ...

    Filing Type:    PU
    Biolase, Inc.

    Biolase, Inc.

    BIOLASE, Inc. is a medical device company and global market leader in the manufact...

    BIOLASE, Inc. is a medical device company and g...

    Filing Type:    PU
    Hera Health Solutions, Inc.

    Hera Health Solutions, Inc.

    Hera Health Solutions is a pharmaceutical device company based in Memphis, Tenness...

    Hera Health Solutions is a pharmaceutical devic...

    Amount Raised:    $256,955.00
    Fundraising Status:    SD
    Filing Type:    CF
    Integra LifeSciences Holdings Corporation

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences, a world leader in medical devices, is dedicated to limiting ...

    Integra LifeSciences, a world leader in medical...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.